Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children

Vaccine

Volumn 23, Issue 31, 2005, Pages 4082-4087

  Duval, Bernard ^a,b,c,d   Gîlca, Vladimir ^b   Boulianne, Nicole ^a,b   Deceuninck, Genevieve ^b   Rochette, Louis ^a   De Serres, Gaston ^a,b,c  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d NONE   (Canada)

Author keywords

Hepatitis A and B; Immunogenicity; Vaccination

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; VACCINATION;

CANADA; CHILD; FEMALE; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; MALE; VACCINES, COMBINED; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 20444367613     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.07.022     Document Type: Article

References (50)

1. CDC, Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1-19.
2. G.M. Keating, and S. Noble Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B Drugs 63 10 2003 1021 1051
3. R.S. Koff Immunogenicity of hepatitis B vaccines: implications of immune memory Vaccine 20 2002 3695 3701
4. T. Coates, R. Wilson, G. Patrick, F. André, and V. Watson Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines Clin. Ther. 23 3 2001 392 403
5. C.J. Oon, K.L. Tan, K.T. Goh, Y.M. Wong-Young, O. Viegas, and Mc. Carthy Evaluation of a low dose of hepatitis B vaccine given within a childhood immunisation programme in Singapore J. Infect. 13 1986 255 267
6. A. Milne, and C. Moyes Response to hepatitis B vaccine in New Zealand children using low doses in a two-month versus six-month schedule Viral Hepatitis 1988 977 979
7. Kane M. Reduced doses of hepatitis B vaccines: is it a good idea? Bull World Organiz 1995;73(4):529-30.
8. L.G. Heron, K.G. Chant, and B.B. Jalaludin A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart Vaccine 20 2002 3472 3476
9. K. Levie, J. Beran, F. Collard, and C. Nguyen Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years Vaccine 20 2002 2579 2584
10. S. Iwarson Are we giving too many doses of hepatitis A and B vaccines? Vaccine 20 16 2002 2017 2018
11. J.N. Wilson, and D.J. Nokes Do we need 3 doses of hepatitis B vaccine? Vaccine 17 1999 2667 2673
12. K. Van Herck, P. Van Damme, F. Collard, and S. Thoelen Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years Scand. J. Gastroenterol. 34 1999 1236 1240
13. M. Van der Wielen, P. Van Damme, and F. Collard A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years Pediatr. Infect. Dis. J. 19 9 1999 848 853
14. W.M. Cassidy, B. Watson, V.A. Ioli, K. Williams, S. Bird, and D.J. West A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory Pediatrics 107 4 2001 626 631
15. P.A. Czeschinski, N. Binding, and U. Witting Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccine Vaccine 18 2000 1074 1080
16. G. Greub, B. Genton, A. Safary, S. Thoelen, and P.C. Frei Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix™ Vaccine 19 2000 1113 1117
17. S. Thoelen, P. Van Dame, A. Leentvarr-Kuepers, G. Leroux-Roels, M. Bruguera, and P.C. Frei The first combined vaccine against hepatitis A and B: an overview Vaccine 17 1999 1657 1662
18. P. Van Damme, and M. Van der Wielen Combining hepatitis A and B vaccination in children and adolescents Vaccine 19 2001 2407 2412
19. L.M. Kollar, S.L. Rosenthal, and F.M. Biro Hepatitis B vaccine series compliance in adolescents Pediatr. Infect. Dis. J. 13 11 1994 1006 1008
20. H.P. Levaux, W.H. Schonfeld, J.M. Pellissier, W.M. Cassidy, S.K. Sheriff, and C. Fitzsimon Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents Pediatrics 108 2 2001 317 325
21. B. Duval, N. Boulianne, G. De Serres, N. Laflamme, P. De Wals, and R. Massé Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children Vaccine 18 2000 1467 1472
22. Duval B, Boucher F, Dion R, Dupont M, Robinson E, Tremblay M, et al. Contrôle de l'hépatite A par l'immunisation au Québec: rapport final du groupe de travail. Ministère de la Santé et des Services Sociaux du Québec: Québec, Québec; 1997. p. 90.
23. D.P. Greenberg, C.M. Vadheim, V.K. Wong, M. Marcy, S. Partridge, and T. Green Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age Pediatr. Infect. Dis. J. 15 7 1996 590 596
24. D.J. West Clinical experience with hepatitis B vaccines Am. J. Infect. Control 17 3 1989 172 180
25. B. Duval, N. Boulianne, G. De Serres, P. De Wals, R. Massé, and G. Trudeau Should children with isolated anti-HBs or anti-HBc be immunized against hepatitis B virus? JAMA 278 13 1997 1064
26. S. Kashiwagi, J. Hayashi, A. Noguchi, K. Nakashima, M. Hirata, and W. Kajiyama Evaluation of micro particle enzyme immunoassay (MEIA) for the demonstration of antibody to hepatitis B surface antigen Kansenshogaku Zasshi 66 3 1992 390 399
27. L.S. Racela, G.E. Tegmeier, G.R. Hodges, and J.S. Reed Comparison of two testing methods to determine hepatitis B surface antibody response to hepatitis B vaccine among health-care workers Am. J. Clin. Pathol. 86 4 1986 527 529
28. N.K. Blackburn, B.D. Schoub, and K.F. O'Connell Comparison of an enzyme-immunoassay with a radio-immunoassay method for the detection of the hepatitis markers anti-HBs, anti-HBc and HBsAg S. Afr. Med. J. 78 2 1990 102 103
29. E. Tanzi, S. Perin, M. De Paschale, R. Cometti, and P. Ferroni Evaluation of an immunoenzymatic method for the simultaneous determination of HBsAg and anti-HBs Quad. Sclavo. Diagn. 21 2 1985 190 198
30. S.D. Lee, K.J. Lo, Y.T. Tsai, C.Y. Chan, H.C. Lin, and J.C. Wu Comparison of enzyme- and radio-immunosassay kits to detect hepatitis B surface antibody response among hepatitis B vaccinees Zhonghua Min Guo We Sheng Wu Ji Mian Yi Xue Za Zhi 21 3 1988 158 164
31. J.A. McCready, D. Morens, H.A. Fields, P.J. Coleman, M. Kane, and G. Schatz Evaluation of enzyme immunoassay (EIA) as a screening method for hepatitis B markers in an open population Epidemiol. Infect. 107 3 1991 673 684
32. Sensitivity of the test for antibody to hepatitis B surface antigen - United States. MMWR 1993;42(36):707-12.
33. ST. Goldstein, and A.E. Fiore Toward the global elimination of hepatitis B virus transmission J. Pediatr. 139 3 2001 343 345
34. R. Harpaz, B.J. McMahon, H.S. Margolis, C.N. Shapiro, D. Havron, and G. Carpenter Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program J. Infect. Dis. 181 2 2000 413 418
35. S. Iwarson, W. Jilg, and T. Stroffolini Substantial decline of notified hepatitis B in major parts of Europe after 1985 Scand. J. Infect. Dis. 26 1 1994 19 22
36. Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR 2003;52(36):868-70.
37. A. Williams Reduction in the hepatitis B related burden of disease-measuring the success of universal immunisation programs Commun. Dis. Intell. 26 3 2002 458 460
38. P. Bonanni, G. Pesavento, A. Bechini, E. Tiscione, F. Mannelli, and C. Benucci Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy Vaccine 21 7-8 2003 685 691
39. E. Mast, F. Mahoney, M. Kane, and H. Margolis Hepatitis B vaccine Vaccines 2004 Elsevier Philadelphia, PA p. 299-338
40. J. Wiström, C. Ahlm, S. Lundberg, B. Settergren, and A. Tärnvik Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose Vaccine 17 1999 2162 2165
41. S. Iwarson, M. Lindh, and L. Widerström Excellent booster response 4-6 years after a single primary dose of an inactivated hepatitis A vaccine Scand. J. Infect. Dis. 34 2002 110 111
42. P. Landry, S. Tremblay, R. Darioli, and B. Genton Inactivated hepatitis A vaccine booster given >24 months after the primary dose Vaccine 19 2001 399 402
43. ®) in adults Vaccine 19 2001 4710 4719
44. R.C. Guptan, V. Thakur, A. Safary, and S.K. Sarin Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix™ in healthy Indian children Vaccine 20 2002 2102 2106
45. G. Leroux-Roels, E. Moreau, I. Desombere, and A. Safary Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young health adults Scand. J. Gastroenterol. 31 1996 1027 1031
46. E.L. Lopez, M. Del Carmen Xifro, L.E. Torrado, M. Fabiana de Rosa, R. Gomez, and R. Dumas Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children Pediatr. Infect. Dis. J. 20 1 2001 48 52
47. M.A. Burgess, A.J. Rodger, S.A. Waite, and F. Collard Comparative immunogenicity and safety of two dosing schedules of a combine hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study Vaccine 19 2001 4835 4841
48. C.Y. Chan, S.D. Lee, M.I. Yu, Y.J. Wang, F.Y. Chang, and K.J. Lo Long-term follow-up of hepatitis A vaccination in children Vaccine 17 1999 369 372
49. R. Dagan, D. Greenberg, P. Goldenbertg-Gehtman, E. Vidor, P. Briantais, and V. Pinsk Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine Vaccine 17 1999 1919 1925
50. P. Van Damme, G. Leroux-Roels, B. Law, F. Diaz-Mitoma, I. Desombere, and F. Collard Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults J. Med. Virol. 65 2001 6 13